CD8A and neoplasm: To explore the extent to which FNIII 11-EDA-generated CD8+ T cells were capable of cell killing, i.e. function as cytotoxic T lymphocytes (CTLs), we employed a thymoma tumor model in which the cells express the xenoantigen OVA (E.G7-OVA).